Optiver Holding’s Kura Oncology KURA Stock Holding History

Optiver Holding’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-498	Closed	-$4.41K	–	2742
2025 Q3	$4.41K	Buy	+498	New	+$3.55K	﹤0.01%	1853

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Optiver Holding's KURA Position: Q4 2025 in Review

Optiver Holding sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 498 shares — an estimated $4.41K sold.

Optiver Holding first reported a position in KURA in Q3 2025 and held it in 1 quarter. The position peaked at $4.41K in Q3 2025. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

Optiver Holding reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
Optiver Holding sold 498 Kura Oncology shares in Q4 2025, an estimated $4.41K.
Optiver Holding first reported a position in Kura Oncology in Q3 2025 and held it in 1 quarter.
Optiver Holding's Kura Oncology position peaked at $4.41K in Q3 2025.
215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.